相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Oncolytic peptide LTX-315 induces anti-pancreatic cancer immunity by targeting the ATP11B-PD-L1 axis
Tianyu Tang et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
James Spicer et al.
CLINICAL CANCER RESEARCH (2021)
LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells
Takahiro Yamazaki et al.
ONCOIMMUNOLOGY (2021)
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
Ilio Vitale et al.
TRENDS IN CANCER (2021)
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
Tianyu Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Oncolysis without viruses - inducing systemic anticancer immune responses with local therapies
Oliver Kepp et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
A Novel Peptide Oligomer of Bacitracin Induces M1 Macrophage Polarization by Facilitating Ca2+Influx
Seon Yeong Ji et al.
NUTRIENTS (2020)
The Novel Oncolytic Compound LTX-401 Induces Antitumor Immune Responses in Experimental Hepatocellular Carcinoma
Brynjar Mauseth et al.
MOLECULAR THERAPY-ONCOLYTICS (2019)
Enhanced T-lymphocyte infiltration in a desmoid tumor of the thoracic wall in a young woman treated with intratumoral injections of the oncolytic peptide LTX-315: a case report
Nina Louise Jebsen et al.
JOURNAL OF MEDICAL CASE REPORTS (2019)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma
Jason Chesney et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The anticancer peptide RT53 induces immunogenic cell death
Ewa Pasquereau-Kotula et al.
PLOS ONE (2018)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Radiotherapy and immunotherapy: a beneficial liaison?
Ralph R. Weichselbaum et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
In Vitro and in Vivo Anticancer Activity of Pardaxin against Proliferation and Growth of Oral Squamous Cell Carcinoma
Yifan Han et al.
MARINE DRUGS (2016)
The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade
T. Yamazaki et al.
CELL DEATH AND DIFFERENTIATION (2016)
Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315
Ketil Andre Camilio et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice
Yong-sheng Wang et al.
CLINICAL CANCER RESEARCH (2009)
Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Dipyaman Ganguly et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
分享论文
